DIASTAT DIN 02519089
Health Canada record
| Active ingredient(s) | DIAZEPAM 15 MG |
|---|---|
| Dosage form | Gel |
| Route | Rectal |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| Class | Human |
| ATC | N05BA01 DIAZEPAM |
| Original market date | 21-Apr-2022 |
| Current status date | 21-Apr-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIAZEPAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02238162 | DIASTAT | BAUSCH HEALTH, CANADA INC. | Gel | DIAZEPAM 5 MG | Marketed |
| 02519070 | DIASTAT | BAUSCH HEALTH, CANADA INC. | Gel | DIAZEPAM 10 MG | Marketed |
| 00405337 | DIAZEPAM | AA PHARMA INC | Tablet | DIAZEPAM 10 MG | Marketed |
| 00362158 | DIAZEPAM | AA PHARMA INC | Tablet | DIAZEPAM 5 MG | Marketed |
| 00405329 | DIAZEPAM | AA PHARMA INC | Tablet | DIAZEPAM 2 MG | Marketed |
| 00399728 | DIAZEPAM INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | DIAZEPAM 5 MG | Marketed |
| 00013285 | VALIUM | SEARCHLIGHT PHARMA INC | Tablet | DIAZEPAM 5 MG | Marketed |
| 02247176 | BIO-DIAZEPAM | BIOMED PHARMA | Tablet | DIAZEPAM 10 MG | Cancelled Post Market |
| 02247174 | BIO-DIAZEPAM | BIOMED PHARMA | Tablet | DIAZEPAM 5 MG | Cancelled Post Market |
| 02247173 | BIO-DIAZEPAM | BIOMED PHARMA | Tablet | DIAZEPAM 2 MG | Cancelled Post Market |
| 02065614 | DIAZEMULS | ACTAVIS GROUP PTC EHF | Emulsion | DIAZEPAM 5 MG | Cancelled Post Market |
| 02232751 | DIAZEPAM 10MG TABLETS | LABORATOIRES CONFAB INC | Tablet | DIAZEPAM 10 MG | Cancelled Pre Market |
| 00434388 | DIAZEPAM 10TAB 10MG | PRO DOC LIMITEE | Tablet | DIAZEPAM 10 MG | Cancelled Post Market |
| 02232737 | DIAZEPAM 2MG TABLETS | LABORATOIRES CONFAB INC | Tablet | DIAZEPAM 2 MG | Cancelled Pre Market |
| 00434396 | DIAZEPAM 2TAB 2MG | PRO DOC LIMITEE | Tablet | DIAZEPAM 2 MG | Cancelled Post Market |
| 00313580 | DIAZEPAM 5 TAB | PRO DOC LIMITEE | Tablet | DIAZEPAM 5 MG | Cancelled Post Market |
| 02232749 | DIAZEPAM 5MG TABLETS | LABORATOIRES CONFAB INC | Tablet | DIAZEPAM 5 MG | Cancelled Pre Market |
| 02243240 | DIAZEPAM AUTOINJECTOR | MERIDIAN MEDICAL TECHNOLOGIES INC. | Liquid | DIAZEPAM 10 MG | Cancelled Post Market |
| 02386143 | DIAZEPAM INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | DIAZEPAM 10 MG | Cancelled Post Market |
| 02385392 | DIAZEPAM INJECTION USP | HIKMA CANADA LIMITED | Solution | DIAZEPAM 5 MG | Dormant |
| 00272639 | E PAM TAB 10MG | ICN CANADA LTD. | Tablet | DIAZEPAM 10 MG | Cancelled Post Market |
| 00272647 | E PAM TAB 2MG | ICN CANADA LTD. | Tablet | DIAZEPAM 2 MG | Cancelled Post Market |
| 00280429 | E PAM TAB 5MG | ICN CANADA LTD. | Tablet | DIAZEPAM 5 MG | Cancelled Post Market |
| 00276650 | MEVAL 2 | MEDIC LABORATORY LTÉE | Tablet | DIAZEPAM 2 MG | Cancelled Post Market |
| 00276642 | MEVAL 5 | MEDIC LABORATORY LTÉE | Tablet | DIAZEPAM 5 MG | Cancelled Post Market |
| 00272450 | NOVO-DIPAM TAB 10MG | NOVOPHARM LIMITED | Tablet | DIAZEPAM 10 MG | Cancelled Post Market |
| 00272434 | NOVO-DIPAM TAB 2MG | NOVOPHARM LIMITED | Tablet | DIAZEPAM 2 MG | Cancelled Post Market |
| 00272442 | NOVO-DIPAM TAB 5MG | NOVOPHARM LIMITED | Tablet | DIAZEPAM 5 MG | Cancelled Post Market |
| 02247492 | PMS-DIAZEPAM | PHARMASCIENCE INC | Tablet | DIAZEPAM 10 MG | Cancelled Post Market |
| 02247490 | PMS-DIAZEPAM | PHARMASCIENCE INC | Tablet | DIAZEPAM 2 MG | Cancelled Post Market |
| 02247491 | PMS-DIAZEPAM | PHARMASCIENCE INC | Tablet | DIAZEPAM 5 MG | Cancelled Post Market |
| 00891797 | PMS-DIAZEPAM SOLUTION 1MG/ML | PHARMASCIENCE INC | Solution | DIAZEPAM 1 MG | Cancelled Post Market |
| 00013293 | VALIUM 10 TAB | HOFFMANN-LA ROCHE LIMITED | Tablet | DIAZEPAM 10 MG | Cancelled Post Market |
| 00012874 | VALIUM INJ ROCHE 5MG/ML | HOFFMANN-LA ROCHE LIMITED | Liquid | DIAZEPAM 10 MG | Cancelled Post Market |
| 00013765 | VIVOL | AXXESS PHARMA INC. | Tablet | DIAZEPAM 5 MG | Cancelled Post Market |
| 00013757 | VIVOL | CARTER-HORNER CORP. | Tablet | DIAZEPAM 2 MG | Cancelled Post Market |
| 00013773 | VIVOL | AXXESS PHARMA INC. | Tablet | DIAZEPAM 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 26456 | 2021-08-18 | New Drug Submission (NDS) | Response to MHPD advisement letter issued May 22, 2018 ¿ requesting for unique DINs for each marketed presentation of DIASTAT (5 mL, 10 mL, 15 mL) and to update the product monograph to the 2020 format. Administrative: Change in Product Ownership |
International API supply for DIAZEPAM
6 valid EDQM Certificates of Suitability from 6 holders. 5 active FDA Drug Master Files.
Request a quote for DIASTAT